Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen.

Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen.
复制标题

DOI:
10.1038/srep38986
复制
发表时间:
2016-12-16
期刊:
影响因子:
4.6
通讯作者:
Besra GS
Besra GS
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Cox JA;Mugumbate G;Del Peral LV;Jankute M;Abrahams KA;Jervis P;Jackenkroll S;Perez A;Alemparte C;Esquivias J;Lelièvre J;Ramon F;Barros D;Ballell L;Besra GS

文献摘要

参考文献

被引文献

相似文献

高通量表型筛选已重新成为抗生素发现中的筛选工具。这些技术的出现迅速加速了“命中”化合物的鉴定。药物化学优化程序的一个先决条件,需要改善药物样性质的“命中”分子是确定其作用模式。在此,我们将表型筛选与有偏见的靶特异性筛选相结合。肌苷单磷酸脱氢酶(IMPDH)蛋白GuaB2已被鉴定为结核分枝杆菌中的可药用靶标,然而先前鉴定的化合物缺乏进一步开发成铅样分子所需的期望特征。本研究从使用过表达GuaB2的牛分枝杆菌BCG的高通量基于抗性的表型筛选中鉴定了7个新的化学系列。在单次高通量筛选中鉴定命中化合物,通过剂量反应验证并进行进一步的生化分析。还使用分子对接实验对化合物进行了评估,为使用药物化学对其进行进一步优化提供了平台。这项工作证明了GuaB2作为抗结核药物靶标的多功能性和潜力。
High-throughput phenotypic screens have re-emerged as screening tools in antibiotic discovery. The advent of such technologies has rapidly accelerated the identification of ‘hit’ compounds. A pre-requisite to medicinal chemistry optimisation programmes required to improve the drug-like properties of a ‘hit’ molecule is identification of its mode of action. Herein, we have combined phenotypic screening with a biased target-specific screen. The inosine monophosphate dehydrogenase (IMPDH) protein GuaB2 has been identified as a drugable target in Mycobacterium tuberculosis, however previously identified compounds lack the desired characteristics necessary for further development into lead-like molecules. This study has identified 7 new chemical series from a high-throughput resistance-based phenotypic screen using Mycobacterium bovis BCG over-expressing GuaB2. Hit compounds were identified in a single shot high-throughput screen, validated by dose response and subjected to further biochemical analysis. The compounds were also assessed using molecular docking experiments, providing a platform for their further optimisation using medicinal chemistry. This work demonstrates the versatility and potential of GuaB2 as an anti-tubercular drug target.
DOI: 10.1093/nar/gkt1180
发表时间: 2014-01
影响因子: 14.9
作者:
Gutmanas A;Alhroub Y;Battle GM;Berrisford JM;Bochet E;Conroy MJ;Dana JM;Fernandez Montecelo MA;van Ginkel G;Gore SP;Haslam P;Hatherley R;Hendrickx PM;Hirshberg M;Lagerstedt I;Mir S;Mukhopadhyay A;Oldfield TJ;Patwardhan A;Rinaldi L;Sahni G;Sanz-García E;Sen S;Slowley RA;Velankar S;Wainwright ME;Kleywegt GJ
通讯作者: Kleywegt GJ
DOI: 10.1378/chest.08-2427
发表时间: 2009-08-01
期刊: CHEST
影响因子: 9.6
作者:
Velayati, Ali Akbar;Masjedi, Mohammad Reza;Hoffner, Sven Eric
通讯作者: Hoffner, Sven Eric
DOI: 10.1099/mic.0.042549-0
发表时间: 2011-01-01
期刊: MICROBIOLOGY-SGM
影响因子: 2.8
作者:
Usha, Veeraraghavan;Gurcha, Sudagar S.;Besra, Gurdyal S.
通讯作者: Besra, Gurdyal S.
DOI: 10.2217/fmb.10.50
发表时间: 2010-06
影响因子: 3.1
作者:
Matteelli A;Carvalho AC;Dooley KE;Kritski A
通讯作者: Kritski A
DOI: 10.1007/s10822-012-9547-0
发表时间: 2012-06
影响因子: 3.5
作者:
Neves, Marco A. C.;Totrov, Maxim;Abagyan, Ruben
通讯作者: Abagyan, Ruben